Although pentoxifylline may have some benefit in the treatment of recurrent aphthous stomatitis, the benefit is limited. It may have a role in the treatment of patients unresponsive to other treatments, but cannot yet be recommended as a first-line treatment.
No takes yet. Share an insight, caveat, or question.
Thornhill et al. (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: